Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
X
Xtant Medical Holdings Inc
F:XMS
Xtant Medical Holdings Inc
F:XMS
Price:
0.278
EUR
Market Cap:
€36.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Xtant Medical Holdings Inc
F:XMS
|
US |
|
A
|
AppliCAD PCL
SET:APP
|
TH |
|
Remala Abadi Tbk PT
IDX:DATA
|
ID |
|
H
|
Hardwario as
PSE:HWIO
|
CZ |
|
CytoMed Therapeutics Ltd
F:F98
|
SG |
|
F
|
Food and Drinks PCL
SET:F&D
|
TH |
|
O
|
Optimind Pharma Corp
CNSX:OMND
|
CA |
|
B
|
BCPG PCL
SET:BCPG
|
TH |
|
G
|
Green Tech Ventures PCL
SET:GTV
|
TH |
|
F
|
Futebol Clube do Porto Futebol Sad
XMUN:FBC
|
PT |
|
C
|
Coloseum Holding as
PSE:COLOS
|
CZ |
|
I
|
Islandsbanki hf
ICEX:ISB
|
IS |
|
G
|
Getabec PCL
SET:GTB
|
TH |
|
A
|
Asset World Corp PCL
SET:AWC
|
TH |
|
U
|
US Critical Metals Corp
CNSX:USCM
|
CA |
|
M
|
MetroGAS SA
BCBA:METR
|
AR |
|
DFDS A/S
CSE:DFDS
|
DK |
|
F
|
Fastenal Co
F:FAS
|
US |
|
B
|
Bezvavlasy as
PSE:BEZVA
|
CZ |
Wall St Price Targets
XMS Price Forecast
Based on 5 analysts
Based on 5 analysts
+209% Upside
from
€0.278
today
Xtant Medical Holdings Inc (XMS)’s 12-month stock price forecast through October 2027 has a consensus target of €0.859, implying 209% upside. The forecast is based on price targets from 5 Wall Street analysts.
Xtant Medical Holdings Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XMS's stock price target?
Price Target
0.859
EUR
0.859
EUR
According to Wall Street analysts, the average 1-year price target for XMS is 0.859 EUR with a low forecast of 0.511 EUR and a high forecast of 1.327 EUR.
What is the Revenue forecast for Xtant Medical Holdings Inc?
Projected CAGR
3%
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 6 years is 3%.
What is the Gross Profit forecast for Xtant Medical Holdings Inc?
Projected CAGR
5%
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 6 years is 5%.
What is the Operating Income forecast for Xtant Medical Holdings Inc?
Projected CAGR
36%
36%
The compound annual growth rate for Operating Income over the next 6 years is 36%.
What is the Pre-Tax Income forecast for Xtant Medical Holdings Inc?
Projected CAGR
-28%
-28%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -28%.
What is the Net Income forecast for Xtant Medical Holdings Inc?
Projected CAGR
42%
42%
The compound annual growth rate for Net Income over the next 6 years is 42%.